JP5486588B2 - 糖調節のための方法およびシステム - Google Patents

糖調節のための方法およびシステム Download PDF

Info

Publication number
JP5486588B2
JP5486588B2 JP2011503199A JP2011503199A JP5486588B2 JP 5486588 B2 JP5486588 B2 JP 5486588B2 JP 2011503199 A JP2011503199 A JP 2011503199A JP 2011503199 A JP2011503199 A JP 2011503199A JP 5486588 B2 JP5486588 B2 JP 5486588B2
Authority
JP
Japan
Prior art keywords
nerve
signal
time
electrical signal
vagus nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011503199A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011516177A (ja
Inventor
アーノルド ダブリュー． ソーントン，
デニス ドン−ウォン キム，
マーク ビー． ナッドソン，
キャサリン エス． トウェーデン，
リチャード アール． ウィルソン，
Original Assignee
エンテロメディクス インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エンテロメディクス インコーポレイテッド filed Critical エンテロメディクス インコーポレイテッド
Publication of JP2011516177A publication Critical patent/JP2011516177A/ja
Application granted granted Critical
Publication of JP5486588B2 publication Critical patent/JP5486588B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/36167—Timing, e.g. stimulation onset
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators
    • A61N1/37235—Aspects of the external programmer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
JP2011503199A 2008-04-04 2009-04-03 糖調節のための方法およびシステム Expired - Fee Related JP5486588B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4257508P 2008-04-04 2008-04-04
US61/042,575 2008-04-04
PCT/US2009/039420 WO2009124233A1 (en) 2008-04-04 2009-04-03 Methods and systems for glucose regulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013268765A Division JP5937057B2 (ja) 2008-04-04 2013-12-26 糖調節のための方法およびシステム

Publications (2)

Publication Number Publication Date
JP2011516177A JP2011516177A (ja) 2011-05-26
JP5486588B2 true JP5486588B2 (ja) 2014-05-07

Family

ID=40718529

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011503199A Expired - Fee Related JP5486588B2 (ja) 2008-04-04 2009-04-03 糖調節のための方法およびシステム
JP2013268765A Expired - Fee Related JP5937057B2 (ja) 2008-04-04 2013-12-26 糖調節のための方法およびシステム
JP2015239881A Expired - Fee Related JP6140258B2 (ja) 2008-04-04 2015-12-09 糖調節のための方法およびシステム
JP2016247977A Withdrawn JP2017051810A (ja) 2008-04-04 2016-12-21 糖調節のための方法およびシステム

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2013268765A Expired - Fee Related JP5937057B2 (ja) 2008-04-04 2013-12-26 糖調節のための方法およびシステム
JP2015239881A Expired - Fee Related JP6140258B2 (ja) 2008-04-04 2015-12-09 糖調節のための方法およびシステム
JP2016247977A Withdrawn JP2017051810A (ja) 2008-04-04 2016-12-21 糖調節のための方法およびシステム

Country Status (7)

Country Link
US (5) US8483830B2 (enExample)
EP (2) EP2300099A1 (enExample)
JP (4) JP5486588B2 (enExample)
CN (2) CN105031811B (enExample)
AU (1) AU2009231601B2 (enExample)
HK (1) HK1217306A1 (enExample)
WO (1) WO2009124233A1 (enExample)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
US8391970B2 (en) * 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
CN105031811B (zh) * 2008-04-04 2017-09-08 安特罗麦迪克斯公司 用于葡萄糖调节的方法和系统
WO2010006341A1 (en) * 2008-07-11 2010-01-14 Gep Technology, Inc. Apparatus and methods for minimally invasive obesity treatment
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
ES2452484T3 (es) 2008-11-18 2014-04-01 Setpoint Medical Corporation Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
WO2010124128A1 (en) 2009-04-22 2010-10-28 Nevro Corporation Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US8996116B2 (en) * 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CN102573986B (zh) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 用于无导线刺激器的具有袋部的神经封套
EP3323423B1 (en) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
EP2515996B1 (en) 2009-12-23 2019-09-18 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US8825164B2 (en) 2010-06-11 2014-09-02 Enteromedics Inc. Neural modulation devices and methods
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
EP2707094B1 (en) 2011-05-09 2016-02-03 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
WO2013036880A1 (en) 2011-09-08 2013-03-14 Thacker James R Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
EP2788078B1 (en) 2011-12-09 2020-09-02 Metavention, Inc. Therapeutic neuromodulation of the hepatic system
JP6132856B2 (ja) * 2012-03-07 2017-05-24 エンテロメディクス インコーポレイテッド 血圧および心拍数の調節のためのデバイス
AU2013230776B2 (en) 2012-03-08 2015-12-03 Medtronic Af Luxembourg S.A.R.L. Immune system neuromodulation and associated systems and methods
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US9442100B2 (en) 2013-12-18 2016-09-13 Medibotics Llc Caloric intake measuring system using spectroscopic and 3D imaging analysis
US9536449B2 (en) 2013-05-23 2017-01-03 Medibotics Llc Smart watch and food utensil for monitoring food consumption
US9254099B2 (en) 2013-05-23 2016-02-09 Medibotics Llc Smart watch and food-imaging member for monitoring food consumption
US9042596B2 (en) 2012-06-14 2015-05-26 Medibotics Llc Willpower watch (TM)—a wearable food consumption monitor
US8504161B1 (en) * 2012-08-07 2013-08-06 Medtronic, Inc. Modulate vagal signals to reduce inflammation
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
EP2891089A2 (en) * 2012-08-30 2015-07-08 Medtronic MiniMed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US9364609B2 (en) 2012-08-30 2016-06-14 Medtronic Minimed, Inc. Insulin on board compensation for a closed-loop insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
CN108159564A (zh) * 2013-01-28 2018-06-15 重塑生命科学股份有限公司 把疗法施加于患者靶神经的系统
US9529385B2 (en) 2013-05-23 2016-12-27 Medibotics Llc Smart watch and human-to-computer interface for monitoring food consumption
CA2913346A1 (en) 2013-06-05 2014-12-11 Metavention, Inc. Modulation of targeted nerve fibers
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
JP6553623B2 (ja) 2013-09-16 2019-07-31 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 電磁エネルギー生成のための多素子カプラ
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US20160336813A1 (en) 2015-05-15 2016-11-17 NeuSpera Medical Inc. Midfield coupler
EP3753517B1 (en) 2014-05-18 2022-05-11 Neuspera Medical Inc. Midfield coupler
CN104147699A (zh) * 2014-07-31 2014-11-19 李军 一种用于治疗2型糖尿病的腹腔神经丛电刺激系统
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
GB2546713A (en) * 2014-11-03 2017-07-26 Galvani Bioelectronics Ltd Neuromodulation device
AU2015358385B2 (en) 2014-12-03 2020-09-03 Medtronic Ireland Manufacturing Unlimited Company Systems and methods for modulating nerves or other tissue
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
EP3259017B1 (en) * 2015-02-20 2026-05-13 The Feinstein Institutes for Medical Research Device for nerve stimulation for treatment of diseases and disorders
WO2016141184A1 (en) * 2015-03-03 2016-09-09 Georgia Tech Research Corporation Glucose regulation via electrical stimulation of nerves innervating the liver
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
JP2017000437A (ja) * 2015-06-10 2017-01-05 オリンパス株式会社 心筋再生装置
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
WO2017127756A1 (en) 2016-01-20 2017-07-27 Setpoint Medical Corporation Control of vagal stimulation
EP3405255B1 (en) 2016-01-20 2025-12-31 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
EP3407967B1 (en) 2016-01-25 2021-05-19 Nevro Corporation Treatment of congestive heart failure with electrical stimulation, and associated systems
US10981007B2 (en) 2016-05-13 2021-04-20 Georgia Tech Research Corporation Systems, methods, and devices for neuromodulation
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
US9955882B2 (en) 2016-08-31 2018-05-01 Medtronic Xomed, Inc. System to monitor neural integrity
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US11872371B2 (en) 2017-04-20 2024-01-16 The Feinstein Institutes For Medical Research Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
CN112105414B (zh) * 2018-03-09 2025-11-21 通用电气精准医疗有限责任公司 超声神经调节技术
CA3096702A1 (en) 2018-04-12 2019-10-17 Reshape Lifesciences, Inc. Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methods
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods
MX2021009759A (es) * 2019-02-13 2021-10-26 Avent Inc Sistema y metodo de estimulacion electrica portatil.
CN113557058A (zh) * 2019-03-12 2021-10-26 通用电气公司 靶向葡萄糖转运子和/或肠促胰岛素途径的神经调节
WO2020210786A1 (en) 2019-04-12 2020-10-15 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
CN110064130A (zh) * 2019-04-17 2019-07-30 上海黎欧生物科技有限公司 一种胆囊起搏器
US20220193414A1 (en) * 2019-04-18 2022-06-23 Reshape Lifesciences, Inc. Methods and systems for neural regulation
JP2023512447A (ja) 2020-01-13 2023-03-27 ザ ファインスタイン インスティチューツ フォー メディカル リサーチ 脾臓への高密度集束超音波刺激による出血及び出血性疾患の治療
KR20230012585A (ko) 2020-05-21 2023-01-26 더 파인스타인 인스티튜츠 포 메디칼 리서치 미주 신경 자극을 위한 시스템들 및 방법들
US12527977B2 (en) * 2021-02-04 2026-01-20 GE Precision Healthcare LLC Combined neuromodulation techniques
EP4313273A4 (en) * 2021-04-01 2025-01-22 ReShape Lifesciences, Inc. NEUROMODULATION SYSTEM AND METHOD FOR TREATING A HYPOGLYCEMIC CONDITION
US12444497B2 (en) 2021-05-17 2025-10-14 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation
WO2022251366A1 (en) 2021-05-25 2022-12-01 Nevro Corp. Modified high frequency neuromodulation signals, and associated systems and methods
WO2023052937A1 (en) * 2021-09-29 2023-04-06 Cilag Gmbh International Surgical system for altering the body's sensing of food
WO2023070128A1 (en) * 2021-10-22 2023-04-27 Reshape Lifesciences, Inc. Intermittent dual vagus neuromodulation treatment for improved glycemic control in type 2 diabetes
US20250229086A1 (en) 2022-01-20 2025-07-17 Setpoint Medical Corporation Treatment of inflammatory disorders
US20250295924A1 (en) 2022-05-05 2025-09-25 Medtronic, Inc. Systems and methods for monitoring and controlling an implantable pulse generator
US12649059B2 (en) 2022-08-05 2026-06-09 The Feinstein Institutes For Medical Research Methods for reducing bleeding in hemophilia by vagus nerve stimulation to prime platelets

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231988A (en) * 1991-08-09 1993-08-03 Cyberonics, Inc. Treatment of endocrine disorders by nerve stimulation
US5540730A (en) 1995-06-06 1996-07-30 Cyberonics, Inc. Treatment of motility disorders by nerve stimulation
US7599736B2 (en) * 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
WO2004112563A2 (en) * 2003-06-20 2004-12-29 Metacure N.V., Gastrointestinal methods and apparatus for use in treating disorders
US20040249421A1 (en) * 2000-09-13 2004-12-09 Impulse Dynamics Nv Blood glucose level control
IL129032A (en) * 1999-03-17 2006-12-31 Moshe Dudai Stomach strap
US6885888B2 (en) 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
AU2001277926B2 (en) * 2000-07-20 2006-02-16 Bristol-Myers Squibb Company Regulators of PPARdelta(beta) and their use in the treatment of obesity and insulin resistance
US6832114B1 (en) * 2000-11-21 2004-12-14 Advanced Bionics Corporation Systems and methods for modulation of pancreatic endocrine secretion and treatment of diabetes
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
US7702394B2 (en) 2001-05-01 2010-04-20 Intrapace, Inc. Responsive gastric stimulator
US6928320B2 (en) 2001-05-17 2005-08-09 Medtronic, Inc. Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US7239912B2 (en) * 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US7689277B2 (en) * 2002-03-22 2010-03-30 Leptos Biomedical, Inc. Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US7702386B2 (en) * 2002-03-22 2010-04-20 Leptos Biomedical, Inc. Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes
US7689276B2 (en) 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
EP1551499A1 (en) * 2002-10-04 2005-07-13 Microchips, Inc. Medical device for neural stimulation and controlled drug delivery
US7613515B2 (en) * 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
US20040172084A1 (en) * 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US7844338B2 (en) * 2003-02-03 2010-11-30 Enteromedics Inc. High frequency obesity treatment
US7444183B2 (en) * 2003-02-03 2008-10-28 Enteromedics, Inc. Intraluminal electrode apparatus and method
US7620454B2 (en) * 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
US20070060971A1 (en) * 2003-07-21 2007-03-15 Ofer Glasberg Hepatic device for treatment or glucose detection
JP4960700B2 (ja) 2003-07-21 2012-06-27 メタキュアー リミティド 疾患を治療し、血糖を制御する際に使用するための胃腸処置方法および装置
US7711432B2 (en) * 2004-07-26 2010-05-04 Advanced Neuromodulation Systems, Inc. Stimulation system and method for treating a neurological disorder
US8214047B2 (en) 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
WO2006057734A1 (en) 2004-10-21 2006-06-01 Advanced Neuromodulation Systems, Inc. New stimulation design for neuromodulation
US20060122098A1 (en) * 2004-12-08 2006-06-08 Aoki Thomas T System for infusing insulin to a subject to imporve impaired total body tissue glucose processing
EP2298410B1 (en) * 2004-12-27 2013-10-09 The Feinstein Institute for Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US8260426B2 (en) 2008-01-25 2012-09-04 Cyberonics, Inc. Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device
EP1880298B1 (en) 2005-02-17 2016-07-13 Metacure Limited Charger with data transfer capabilities
US7561923B2 (en) 2005-05-09 2009-07-14 Cardiac Pacemakers, Inc. Method and apparatus for controlling autonomic balance using neural stimulation
US20070016262A1 (en) 2005-07-13 2007-01-18 Betastim, Ltd. Gi and pancreatic device for treating obesity and diabetes
US20070027484A1 (en) * 2005-07-28 2007-02-01 Cyberonics, Inc. Autonomic nerve stimulation to treat a pancreatic disorder
US7620455B2 (en) * 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US8041428B2 (en) 2006-02-10 2011-10-18 Electrocore Llc Electrical stimulation treatment of hypotension
WO2007058780A2 (en) * 2005-11-10 2007-05-24 Electrocore, Inc. Electrical stimulation treatment of bronchial constriction
CA2637851C (en) * 2006-01-23 2016-01-05 Rehabtronics Inc. Method of routing electrical current to bodily tissues via implanted passive conductors
WO2007092330A1 (en) 2006-02-03 2007-08-16 Synecor, Llc Intravascular device for neuromodulation
US7711430B2 (en) 2006-02-10 2010-05-04 Electrocore Llc Methods and apparatus for treating anaphylaxis using electrical modulation
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
WO2007137026A2 (en) 2006-05-18 2007-11-29 Cedars-Sinai Medical Center Electrical stimulation of the lower esophageal sphincter
US8634930B2 (en) * 2006-06-30 2014-01-21 Cardiac Pacemakers, Inc. System for providing diabetic therapy
US8068918B2 (en) * 2007-03-09 2011-11-29 Enteromedics Inc. Remote monitoring and control of implantable devices
US20080281365A1 (en) * 2007-05-09 2008-11-13 Tweden Katherine S Neural signal duty cycle
US20080300646A1 (en) * 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300648A1 (en) * 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US8532787B2 (en) 2007-05-31 2013-09-10 Enteromedics Inc. Implantable therapy system having multiple operating modes
US20080300645A1 (en) * 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
US20080300647A1 (en) * 2007-05-31 2008-12-04 Pacesetter, Inc. Treatment of cardiomyopathy, heart failure and cardiac ischemia using stimulation induced secretion of glp-1
WO2009064408A1 (en) 2007-11-12 2009-05-22 Dilorenzo Daniel J Method and apparatus for programming of autonomic neuromodulation for the treatment of obesity
AU2009214632B2 (en) * 2008-02-14 2015-02-19 Reshape Lifesciences, Inc. Treatment of excess weight by neural downregulation in combination with compositions
CN105031811B (zh) * 2008-04-04 2017-09-08 安特罗麦迪克斯公司 用于葡萄糖调节的方法和系统
US20090254133A1 (en) * 2008-04-07 2009-10-08 Wendell Keith F Method for treatment of diabetes by electrostimulatioin
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
BRPI0917925A2 (pt) 2008-08-26 2015-11-10 Centocor Ortho Biotech Inc estimulação da liberação de hormônio da saciedade
DE202010017584U1 (de) 2009-05-08 2012-02-29 Université Libre de Bruxelles Gastrointestinale Vorrichtung
US20120259389A1 (en) 2009-09-21 2012-10-11 Warren Starkebaum Treatment of postprandial hyperglycemia by gastric electrical stimulation
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
CA3160907A1 (en) 2010-05-27 2011-12-01 Ndi Medical, Llc Waveform shapes for treating neurological disorders optimized for energy efficiency
AU2011282294B9 (en) 2010-07-19 2014-09-25 Cardiac Pacemakers, Inc. Minimally invasive lead system for vagus nerve stimulation
WO2012044472A2 (en) 2010-10-01 2012-04-05 Indiana University Research & Technology Corporation Long term vagal nerve stimulation for therapeutic and diagnostic treatment
WO2012060874A2 (en) 2010-11-01 2012-05-10 Udaya Sankar Devanaboyina Methods for diagnosis and treatment of disorders of the gastrointestinal tract. and apparatus for use therewith
US9014813B2 (en) 2010-11-03 2015-04-21 Cleveland Clinic Foundation Apparatus for energy efficient stimulation
WO2012083259A2 (en) 2010-12-17 2012-06-21 Neural Diabetes Foundation, Inc. Method, system and apparatus for control of pancreatic beta cell function to improve glucose homeostatis and insulin production

Also Published As

Publication number Publication date
HK1217306A1 (zh) 2017-01-06
CN105031811B (zh) 2017-09-08
US20210046313A1 (en) 2021-02-18
US20090254143A1 (en) 2009-10-08
JP5937057B2 (ja) 2016-06-22
US20170021174A1 (en) 2017-01-26
AU2009231601A1 (en) 2009-10-08
AU2009231601A2 (en) 2010-11-04
JP2011516177A (ja) 2011-05-26
CN102056645A (zh) 2011-05-11
EP3047874B1 (en) 2022-03-09
US20130079745A1 (en) 2013-03-28
JP2017051810A (ja) 2017-03-16
EP2300099A1 (en) 2011-03-30
US9974955B2 (en) 2018-05-22
JP2016064151A (ja) 2016-04-28
US20190022393A1 (en) 2019-01-24
AU2009231601B2 (en) 2014-02-27
JP6140258B2 (ja) 2017-05-31
CN105031811A (zh) 2015-11-11
US9333340B2 (en) 2016-05-10
US10722714B2 (en) 2020-07-28
CN102056645B (zh) 2015-07-01
US8483830B2 (en) 2013-07-09
JP2014087681A (ja) 2014-05-15
WO2009124233A1 (en) 2009-10-08
EP3047874A1 (en) 2016-07-27

Similar Documents

Publication Publication Date Title
JP6140258B2 (ja) 糖調節のための方法およびシステム
US20250295920A1 (en) Simultaneous multi-site vagus nerve neuromodulation for improved glycemic control system and methods
JP2014028314A (ja) 血圧および心拍数の調節のためのシステム
CN105268100A (zh) 神经调节设备和方法
AU2016201492B2 (en) Methods and systems for glucose regulation
AU2014202313B2 (en) Methods and systems for glucose regulation
HK1227346B (en) Systems for glucose regulation and methods of making such systems
HK1227346A1 (en) Systems for glucose regulation and methods of making such systems
EP4313273A1 (en) Neuromodulation system and methods for the treatment of a hypoglycemic state

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130624

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130627

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130920

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131017

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140221

R150 Certificate of patent or registration of utility model

Ref document number: 5486588

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees